Found: 26
Select item for more details and to access through your institution.
How donanemab data address the coverage with evidence development questions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 3127, doi. 10.1002/alz.13700
- By:
- Publication type:
- Article
Donanemab in Early Symptomatic Alzheimer's Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082733
- By:
- Publication type:
- Article
Healthcare costs incurred by patients before entering GERAS‐US, a prospective, observational study of early Alzheimer's disease: Impact of disease severity and amyloid status.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057253
- By:
- Publication type:
- Article
Health care utilization patterns in early symptomatic AD prior to enrollment into Phase 2/3 clinical trial AMARANTH.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051019
- By:
- Publication type:
- Article
Disease progression and costs at 3‐year follow‐up of GERAS‐US: A 3‐year study of mild cognitive impairment and mild dementia due to Alzheimer's disease in the United States.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057473
- By:
- Publication type:
- Article
Reasons for study exclusion by sex in lanabecestat studies AMARANTH and DAYBREAK‐ALZ: Human/Human trials: Other.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038663
- By:
- Publication type:
- Article
FTS3‐01‐02: SUBGROUP POPULATIONS IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P872, doi. 10.1016/j.jalz.2019.06.4619
- By:
- Publication type:
- Article
DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1666, doi. 10.1016/j.jalz.2018.07.006
- By:
- Publication type:
- Article
P4‐210: LANABECESTAT: SCREENING PERFORMANCE FROM THE AMARANTH STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1521, doi. 10.1016/j.jalz.2018.07.031
- By:
- Publication type:
- Article
PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND TOLERABILITY OF LY3202626, A NOVEL BACE1 INHIBITOR, IN HEALTHY SUBJECTS AND PATIENTS WITH ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P418, doi. 10.1016/j.jalz.2016.06.791
- By:
- Publication type:
- Article
Cost savings from dose rounding of biologic anticancer agents in adults.
- Published in:
- Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 3, p. 246, doi. 10.1177/1078155210366171
- By:
- Publication type:
- Article
Advances in proteomics data analysis and display using an accurate mass and time tag approach.
- Published in:
- Mass Spectrometry Reviews, 2006, v. 25, n. 3, p. 450, doi. 10.1002/mas.20071
- By:
- Publication type:
- Article
Ocular examination findings and selected ophthalmic diagnostic tests in African green monkeys (Chlorocebus aethiops sabaeus).
- Published in:
- Veterinary Ophthalmology, 2024, v. 27, n. 2, p. 158, doi. 10.1111/vop.13132
- By:
- Publication type:
- Article
Eye removal following parotid duct transposition surgery: A survey of current practice among veterinary ophthalmologists.
- Published in:
- Veterinary Ophthalmology, 2019, v. 22, n. 2, p. 213, doi. 10.1111/vop.12639
- By:
- Publication type:
- Article
Effect of a Novel NOP Receptor Agonist (SCH 225288) on Guinea Pig Irritant-Evoked, Feline Mechanically Induced and Canine Infectious Tracheobronchitis Cough.
- Published in:
- Pharmacology, 2009, v. 84, n. 3, p. 153, doi. 10.1159/000235601
- By:
- Publication type:
- Article
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 6, p. 512, doi. 10.1001/jama.2023.13239
- By:
- Publication type:
- Article
Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 4, p. 445, doi. 10.1001/jamaneurol.2020.5505
- By:
- Publication type:
- Article
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 2, p. 199, doi. 10.1001/jamaneurol.2019.3988
- By:
- Publication type:
- Article
Congenital Cataracts and Microphakia with Retinal Dysplasia and Optic Nerve Hypoplasia in a Calf.
- Published in:
- Case Reports in Veterinary Medicine, 2021, p. 1, doi. 10.1155/2021/2064103
- By:
- Publication type:
- Article
Update: The Clinical Pharmacist as Principal Investigator.
- Published in:
- Pharmacotherapy, 2010, v. 30, n. 12, p. 1314, doi. 10.1592/phco.30.12.1314
- By:
- Publication type:
- Article
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12123
- By:
- Publication type:
- Article
Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01160-6
- By:
- Publication type:
- Article
Clinically Negligible Pharmacokinetic and Pharmacodynamic Interactions Between Lanabecestat and Dabigatran Etexilate, a Prototypical P-gp Substrate.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 5, p. 586, doi. 10.1002/jcph.1558
- By:
- Publication type:
- Article
High Levels of Alzheimer Beta-Amyloid Precursor Protein (APP) in Children With Severely Autistic Behavior and Aggression.
- Published in:
- Journal of Child Neurology, 2006, v. 21, n. 6, p. 444, doi. 10.1177/08830738060210062201
- By:
- Publication type:
- Article
Age-related variation in the presentation of childhood stroke varies with inclusion criteria.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Diagnosis and Treatment of Osteoporosis in Patients with Vertebral Compression Fractures.
- Published in:
- Journal of the American Geriatrics Society, 2003, v. 51, n. 4, p. 483, doi. 10.1046/j.1532-5415.2003.51156.x
- By:
- Publication type:
- Article